These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 35179770)

  • 1. Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial.
    Tavakoli A; Molavi Vardanjani H; Namjouyan F; Cramer H; Pasalar M
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1033-1041. PubMed ID: 35179770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the barley-based remedy, a Persian medicine formula, in coronavirus disease 2019 (COVID-19) hospitalized patients: An open-labeled randomized controlled trial.
    Hasheminasab FS; Azimi M; Khodadoost M; Chouban B; Shakeri N; Ghasemi S; Farokhi A; Mokaberinajad R
    Adv Integr Med; 2022 Sep; 9(3):185-190. PubMed ID: 35469143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial.
    Hajibeygi R; Mirghazanfari SM; Pahlavani N; Jalil AT; Alshahrani SH; Rizaev JA; Hadi S; Hadi V; Yekta NH
    Eur J Integr Med; 2022 Oct; 55():102179. PubMed ID: 36035633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a Persian herbal medicine compound on coronavirus disease 2019 (COVID-19): A randomized clinical trial.
    Setayesh M; Karimi M; Zargaran A; Abousaidi H; Shahesmaeili A; Amiri F; Hasheminasab FS
    Integr Med Res; 2022 Sep; 11(3):100869. PubMed ID: 35783542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.
    Wang G; Wu C; Zhang Q; Yu B; LÜ J; Zhang S; Wu G; Wu Y; Zhong Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):542-548. PubMed ID: 32879104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lin YR; Wu FY; Xiao H; Huang JL; Gong BB; Li YL; Lu N; Jiang XH; Sun QX; Zhang JF; Hu JT; Zhao YX; Li CQ
    J Aerosol Med Pulm Drug Deliv; 2021 Apr; 34(2):108-114. PubMed ID: 33691499
    [No Abstract]   [Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acids supplementation improve clinical symptoms in patients with Covid-19: A randomised clinical trial.
    Sedighiyan M; Abdollahi H; Karimi E; Badeli M; Erfanian R; Raeesi S; Hashemi R; Vahabi Z; Asanjarani B; Mansouri F; Abdolahi M
    Int J Clin Pract; 2021 Dec; 75(12):e14854. PubMed ID: 34516692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial.
    Karimi M; Zarei A; Soleymani S; Jamalimoghadamsiahkali S; Asadi A; Shati M; Jafari M; Rezadoost H; Kordafshar G; Naghizadeh A; Mardi R; Namiranian P; Khamechi SP; Ansari N; Adel Mehraban MS; Aliakbarzadeh H; Khanavi M; Esmaealzadeh N; Moravveji A; Salahi M; Khoi M; Razzaghi R; Banafshe HR; Alizadeh M; Akhbari M; Atharizadeh M; Izadikhah A; Elsagh M; Hossein Zade Ghahnavieh M; Eghbalian F; Vanai A; Izadi H; Moravej SAA; Jazayeri SF; Bayat H; Emadi Koochak H; Zargaran A
    Phytother Res; 2021 Nov; 35(11):6295-6309. PubMed ID: 34606123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study protocol for a randomized, controlled trial of acupuncture versus a sham procedure versus standard care alone for the treatment of delirium in acutely hospitalized older adults with a medical illness.
    Levy I; Attias S; Gavrieli S; Oliven R; Neerland BE; Devlin JW; Ben-Arye E; Greenberg D; Schiff E
    Maturitas; 2019 Jun; 124():72-80. PubMed ID: 31097183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial.
    Varnasseri M; Siahpoosh A; Hoseinynejad K; Amini F; Karamian M; Yad MJY; Cheraghian B; Khosravi AD
    Complement Ther Med; 2022 May; 65():102808. PubMed ID: 35093510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019.
    Ali KM; Ali AM; Tawfeeq HM; Figueredo GP; Rostam HM
    J Med Virol; 2021 Jul; 93(7):4532-4536. PubMed ID: 33830538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No independent associations between physical activity and clinical outcomes among hospitalized patients with moderate to severe COVID-19.
    Pinto AJ; Goessler KF; Fernandes AL; Murai IH; Sales LP; Reis BZ; Santos MD; Roschel H; Pereira RMR; Gualano B
    J Sport Health Sci; 2021 Dec; 10(6):690-696. PubMed ID: 34391961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum inflammatory parameters and the disease severity in COVID-19 patients.
    Mardani R; Namavar M; Ghorbi E; Shoja Z; Zali F; Kaghazian H; Aghasadeghi MR; Sadeghi SA; Sabeti S; Darazam IA; Ahmadi N; Mousavi-Nasab SD
    J Clin Lab Anal; 2022 Jan; 36(1):e24162. PubMed ID: 34874079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Adjunctive Effects of Acupuncture for Hospitalized COVID-19 Patients: a Single-Blinded Randomized Clinical Study.
    Helianthi DR; Barasila AC; Harris S; Sinto R; Khaedir Y;
    J Acupunct Meridian Stud; 2022 Aug; 15(4):247-254. PubMed ID: 36521773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review.
    Latarissa IR; Meiliana A; Sormin IP; Sugiono E; Wathoni N; Barliana MI; Lestari K
    Front Pharmacol; 2024; 15():1383359. PubMed ID: 38873430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study.
    Talebi SS; Ghasemi M; Etminani-Esfahani M; Mohammadi Y; Haddadi R
    Pharmacol Rep; 2022 Dec; 74(6):1296-1305. PubMed ID: 35997951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of topical galbanum oil with dry cupping in hospitalized COVID-19 patients: A randomized open-label clinical trial.
    Seydi F; Salehi M; Hashem-Dabaghian F; Emadi F; Gholami-Fesharaki M; Iranzadasl M
    Avicenna J Phytomed; 2023; 13(4):388-399. PubMed ID: 37663385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.